Suppression of promoter-dependent transcriptional activity of inducible nitric oxide synthase by sodium butyrate in colon cancer cells

Cancer Lett. 2002 Mar 28;177(2):155-61. doi: 10.1016/s0304-3835(01)00778-9.

Abstract

Butyrate suppresses the growth of colon cancer cells, inducing differentiation and apoptosis in vitro. Increased expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) has been suggested to be closely involved in colon carcinogenesis. In this study, effects of sodium butyrate on the promoter-dependent transcriptional activity of iNOS and COX-2 genes were investigated in a colon cancer cell line, DLD-1, using a reporter gene assay system. Sodium butyrate significantly reduced promoter-dependent iNOS transcriptional activity dose-dependently at concentrations higher than 0.1 mM. COX-2 transcriptional activity was not suppressed, but slightly increased. While hyperacetylated histones appeared at concentrations of sodium butyrate suppressing iNOS gene promoter activity, promoter-dependent transcriptional activities of iNOS and COX-2 genes were both increased by the histone deacetylase inhibitor trichostatin A. These results suggested that sodium butyrate exhibits differential effects on iNOS and COX-2 genes, acting to suppress iNOS expression via mechanisms independent of histone acetylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Butyrates / pharmacology*
  • Cell Division / drug effects
  • Colonic Neoplasms / enzymology*
  • Colonic Neoplasms / genetics
  • Colonic Neoplasms / pathology
  • Humans
  • Nitric Oxide Synthase / biosynthesis*
  • Nitric Oxide Synthase / genetics*
  • Nitric Oxide Synthase Type II
  • Promoter Regions, Genetic / drug effects
  • Promoter Regions, Genetic / genetics
  • Transcriptional Activation / drug effects
  • Tumor Cells, Cultured

Substances

  • Butyrates
  • NOS2 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II